MK-677 (Ibutamoren): Potential Benefits, Risks, and What the Research Actually Says

MK-677 (Ibutamoren): Potential Benefits, Risks, and What the Research Actually Says

MK-677, also known as ibutamoren, is often discussed in bodybuilding and performance circles as a compound that may increase growth hormone and IGF-1 levels. Online, it is sometimes marketed in ways that make it sound simple, safe, and highly effective. The real picture is more complicated.

While MK-677 has been studied in clinical research, it is not approved for human use as a medicine, and regulators have also made clear that ibutamoren is not a lawful dietary supplement ingredient in the United States. The current evidence suggests there may be some physiological effects worth understanding, but there are also real uncertainties and risks. (U.S. Food and Drug Administration)

What is MK-677?

MK-677 is an orally active ghrelin receptor agonist and growth hormone secretagogue. In simple terms, it is a compound designed to stimulate the body’s own release of growth hormone, which can then raise levels of insulin-like growth factor 1 (IGF-1). Early clinical studies found that MK-677 increased growth hormone secretion and raised IGF-1 in adults, including older adults. (PubMed)

Because of those effects, MK-677 has been studied for areas such as body composition, bone metabolism, sleep, and recovery from age-related decline. However, research interest does not equal regulatory approval, and the existence of studies should not be confused with proof of long-term safety or effectiveness for general consumers. (PubMed)

Is MK-677 approved for humans?

No. MK-677 is not FDA-approved for human use as a prescription medicine, and the FDA has also stated that ibutamoren is excluded from the definition of a dietary supplement under U.S. law. In recent warning letters, the agency described products containing MK-677/ibutamoren as unapproved new drugs. (U.S. Food and Drug Administration)

That distinction matters. A substance being sold online does not mean it has passed the normal standards for approved human medicines. It also does not mean the dose, purity, label accuracy, or contamination risk have been adequately controlled.

Potential benefits discussed in the research

It is important to frame this carefully: these are potential effects seen in specific studies, not guaranteed real-world outcomes.

1. Increased growth hormone and IGF-1

Some of the strongest evidence around MK-677 is that it can raise growth hormone secretion and IGF-1 levels. In older adults, daily oral administration increased these markers and in some cases restored IGF-1 levels closer to those seen in younger adults. (PubMed)

2. Possible increases in fat-free mass

A randomized trial in healthy older adults reported that MK-677 increased fat-free mass over 12 months. That finding is one reason the compound attracts attention in muscle-building discussions. However, that same study did not show clear improvement in every clinical outcome people might expect, and “fat-free mass” does not automatically mean meaningful gains in strength, performance, or health. (PubMed)

3. Effects on bone turnover markers

Some clinical work found that MK-677 increased markers of bone turnover, suggesting a possible influence on bone metabolism. That is scientifically interesting, but it is still not the same as proving better fracture prevention or broad bone-health benefits in everyday users. (PubMed)

4. Possible effects on sleep

Older studies suggested MK-677 may improve aspects of sleep quality while also increasing growth hormone secretion. This is one of the lesser-discussed areas of the literature, but it appears in the published research. (PubMed)

Risks and concerns

This is where balanced coverage matters most. Even when a compound shows measurable biological effects, that does not make it low-risk.

1. Not approved, not standardized, and often sold in a risky market

One of the biggest concerns is not just the molecule itself, but the way it is often sold. The FDA has warned about products containing ibutamoren and has also flagged cases where products contained hidden ibutamoren not listed on the label. That raises obvious quality-control and consumer safety concerns. (U.S. Food and Drug Administration)

2. Blood sugar and insulin concerns

Published studies have reported that MK-677 can increase fasting and post-meal insulin, and may also raise postprandial glucose. Longer-term discussion in the literature has also noted concerns about reduced insulin sensitivity and worsening glycaemic control in some settings. This is especially relevant for anyone with diabetes, prediabetes, metabolic syndrome, or other blood-sugar concerns. (PubMed)

3. Appetite increase and water retention

Because MK-677 acts through ghrelin-related pathways, increased appetite is commonly discussed. Reports in the literature and case discussions also mention issues such as oedema/water retention and muscle discomfort. These effects may sound minor online, but for some people they can be significant and misleading when interpreting bodyweight changes. (PubMed)

4. Limited long-term safety data in real-world users

A major problem with internet discussions around MK-677 is that they often overstate certainty. The available studies do not provide strong reassurance for unsupervised long-term use by healthy people seeking physique or performance goals. The evidence base is limited, often focused on narrow populations, and does not justify casual assumptions about safety. (PubMed)

5. Case reports of possible liver injury

Case reports do not prove that every user will experience the same problem, but they can still act as warning signals. A 2025 PubMed-indexed case report described transaminitis/liver injury in a man who had been taking MK-677, with liver tests returning toward normal after stopping. That is not enough to define the full risk profile, but it is another reason not to treat MK-677 as harmless. (PubMed)

What the research does and does not show

A common mistake in supplement-style articles is to turn “interesting data” into “proven benefit.” That is not what the science supports.

The research does suggest that MK-677 can:

  • increase growth hormone secretion,

  • raise IGF-1,

  • affect body composition markers,

  • and influence sleep and bone turnover in some study settings. (PubMed)

But the research does not clearly prove that MK-677 is a safe, effective, or appropriate tool for:

Why “research chemical” or “for laboratory use only” labels are not reassuring

Some products are marketed with phrases like “research use only,” but that does not make them safer. In practice, these labels often sit alongside marketing that clearly targets consumers interested in physique or performance outcomes. Regulators have repeatedly taken action against sellers making these kinds of claims for unapproved compounds, including MK-677. (U.S. Food and Drug Administration)

For consumers, the main issue is simple: if a substance is unapproved, sold outside normal pharmaceutical safeguards, and sometimes found hidden in products, there is added uncertainty before you even get to the pharmacology itself. (U.S. Food and Drug Administration)

Final takeaway

MK-677 is a compound with real biological activity, which is exactly why it should be approached carefully. Research suggests it can increase growth hormone and IGF-1, and it may influence fat-free mass, sleep, and bone-related markers in some populations. At the same time, there are legitimate concerns around blood sugar, insulin sensitivity, fluid retention, product quality, and the lack of approval for human use. (PubMed)

The most responsible conclusion is that MK-677 should not be presented as a proven wellness shortcut or a safe over-the-counter muscle-building aid. A careful, evidence-based discussion should make clear that it remains unapproved, not a lawful dietary supplement ingredient in the U.S., and insufficiently established for routine human use. (U.S. Food and Drug Administration)

References

  1. FDA warning letter stating ibutamoren is excluded from the dietary supplement definition and that related products are unapproved new drugs. (U.S. Food and Drug Administration)

  2. FDA warning letter referencing “GE Labs MK 677” as an unapproved new drug. (U.S. Food and Drug Administration)

  3. FDA consumer warning noting hidden ibutamoren in a marketed product. (U.S. Food and Drug Administration)

  4. Chapman IM et al. PubMed: MK-677 increased GH and IGF-1 in older adults. (PubMed)

  5. Murphy MG et al. PubMed: MK-677 increased IGF-1 and related endocrine markers. (PubMed)

  6. Nass R et al. PubMed: randomized trial on body composition and clinical outcomes in healthy older adults. (PubMed)

  7. Murphy MG et al. PubMed: MK-677 and bone turnover markers in older adults. (PubMed)

  8. Copinschi G et al. PubMed: prolonged MK-677 treatment and sleep quality. (PubMed)

  9. Chapman IM et al. PubMed: increases in fasting/postprandial insulin and glucose after MK-677. (PubMed)

  10. Sigalos JT et al. PubMed review on safety and efficacy of growth hormone secretagogues. (PubMed)

  11. Cobani E et al. PubMed case report on hepatotoxicity/transaminitis associated with MK-677 use. (PubMed

Back to blog